Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Sanchez-Pernaute, R; Harvey-White, J; Cunningham, J; Bankiewicz, KS
   Functional effect of adeno-associated virus mediated gene transfer of aromatic L-amino acid decarboxylase into the striatum of 6-OHDA-lesioned rats
   MOLECULAR THERAPY
   
   R. Sanchez-Pernaute et al., "Functional effect of adeno-associated virus mediated gene transfer of aromatic L-amino acid decarboxylase into the striatum of 6-OHDA-lesioned rats", MOL THER, 4(4), 2001, pp. 324-330
2. Jameson, GNL; Linert, W
   The oxidation of 6-hydroxydopamine in aqueous solution. Part 2. Speciationand product distribution with iron(III) as oxidant
   JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2
   
   G.N.L. Jameson e W. Linert, "The oxidation of 6-hydroxydopamine in aqueous solution. Part 2. Speciationand product distribution with iron(III) as oxidant", J CHEM S P2, (4), 2001, pp. 563-568
3. Bezard, E; Brotchie, JM; Gross, CE
   Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies
   NATURE REVIEWS NEUROSCIENCE
   
   E. Bezard et al., "Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies", NAT REV NEU, 2(8), 2001, pp. 577-588
4. Tang, L; Frank, G
   Identification and characterization of an aromatic amino acid decarboxylase from the filarial nematode, Dirofilaria immitis
   BIOLOGICAL CHEMISTRY
   
   L. Tang e G. Frank, "Identification and characterization of an aromatic amino acid decarboxylase from the filarial nematode, Dirofilaria immitis", BIOL CHEM, 382(1), 2001, pp. 115-122
5. Hashimoto, T; Shindo, M; Yanagisawa, N
   Enhanced associated movements in the contralateral limbs elicited by briskvoluntary contraction in choreic disorders
   CLINICAL NEUROPHYSIOLOGY
   
   T. Hashimoto et al., "Enhanced associated movements in the contralateral limbs elicited by briskvoluntary contraction in choreic disorders", CLIN NEU, 112(9), 2001, pp. 1612-1617
6. Hartleb, J; Arndt, R
   Cysteine and indole derivatives as markers for malignant melanoma
   JOURNAL OF CHROMATOGRAPHY B
   
   J. Hartleb e R. Arndt, "Cysteine and indole derivatives as markers for malignant melanoma", J CHROMAT B, 764(1-2), 2001, pp. 409-443
7. Jung, YJ; Youn, JY; Ryu, JC; Surh, YJ
   Salsolinol, a naturally occurring tetrahydroisoquinoline alkaloid, inducesDNA damage and chromosomal aberrations in cultured Chinese hamster lung fibroblast cells
   MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
   
   Y.J. Jung et al., "Salsolinol, a naturally occurring tetrahydroisoquinoline alkaloid, inducesDNA damage and chromosomal aberrations in cultured Chinese hamster lung fibroblast cells", MUT RES-F M, 474(1-2), 2001, pp. 25-33
8. Ranasinghe, JGS; Liu, MC; Sakakibara, Y; Takeshita, Y; Fukuda, N; Nasu, T; Suiko, M
   Stereoselective and manganese-dependent sulfation and urinary excretion ofD-form and L-form meta-tyrosine O-sulfate by Sprague-Dawley rats
   JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC
   
   J.G.S. Ranasinghe et al., "Stereoselective and manganese-dependent sulfation and urinary excretion ofD-form and L-form meta-tyrosine O-sulfate by Sprague-Dawley rats", J MOL CAT B, 12(1-6), 2001, pp. 131-136
9. Glasauer, FE
   Restless legs syndrome
   SPINAL CORD
   
   F.E. Glasauer, "Restless legs syndrome", SPINAL CORD, 39(3), 2001, pp. 125-133
10. Hawi, Z; Foley, D; Kirley, A; McCarron, M; Fitzgerald, M; Gill, M
    Dopa decarboxylase gene polymorphisms and attention deficit hyperactivity disorder (ADHD): no evidence for association in the Irish population
    MOLECULAR PSYCHIATRY
    
    Z. Hawi et al., "Dopa decarboxylase gene polymorphisms and attention deficit hyperactivity disorder (ADHD): no evidence for association in the Irish population", MOL PSYCHI, 6(4), 2001, pp. 420-424
11. Rajput, AH
    Levodopa prolongs life expectancy and is non-toxic to substantia nigra
    PARKINSONISM & RELATED DISORDERS
    
    A.H. Rajput, "Levodopa prolongs life expectancy and is non-toxic to substantia nigra", PARKINS R D, 8(2), 2001, pp. 95-100
12. Nutt, JG
    Motor fluctuations and dyskinesia in Parkinson's disease
    PARKINSONISM & RELATED DISORDERS
    
    J.G. Nutt, "Motor fluctuations and dyskinesia in Parkinson's disease", PARKINS R D, 8(2), 2001, pp. 101-108
13. Jankovic, J; Tintner, R
    Dystonia and parkinsonism
    PARKINSONISM & RELATED DISORDERS
    
    J. Jankovic e R. Tintner, "Dystonia and parkinsonism", PARKINS R D, 8(2), 2001, pp. 109-121
14. Hwang, WJ; Calne, DB; Tsui, JKC; de la Fuente-Fernandez, R
    The long-term response to levodopa in dopa-responsive dystonia
    PARKINSONISM & RELATED DISORDERS
    
    W.J. Hwang et al., "The long-term response to levodopa in dopa-responsive dystonia", PARKINS R D, 8(1), 2001, pp. 1-5
15. Kuopio, AM; Marttila, RJ; Helenius, H; Rinne, UK
    Familial occurrence of Parkinson's disease in a community-based case-control study
    PARKINSONISM & RELATED DISORDERS
    
    A.M. Kuopio et al., "Familial occurrence of Parkinson's disease in a community-based case-control study", PARKINS R D, 7(4), 2001, pp. 297-303
16. Fredriksson, A; Schroder, N; Eriksson, P; Izquierdo, I; Archer, T
    Neonatal iron potentiates adult MPTP-induced neurodegenerative and functional deficits
    PARKINSONISM & RELATED DISORDERS
    
    A. Fredriksson et al., "Neonatal iron potentiates adult MPTP-induced neurodegenerative and functional deficits", PARKINS R D, 7(2), 2001, pp. 97-105
17. Gasser, T; Dichgans, M; Finsterer, J; Hausmanowa-Petrusewicz, I; Jurkat-Rott, K; Klopstock, T; LeGuern, E; Lehesjoki, AE; Lehmann-Horn, F; Lynch, T; Morris, H; Rossor, M; Steinlein, OK; Wood, N; Zaremba, J; Zeviani, M; Zoharn, A
    EFNS task force on molecular diagnosis of neurologic disorders - Guidelines for the molecular diagnosis of inherited neurologic diseases - First of two parts
    EUROPEAN JOURNAL OF NEUROLOGY
    
    T. Gasser et al., "EFNS task force on molecular diagnosis of neurologic disorders - Guidelines for the molecular diagnosis of inherited neurologic diseases - First of two parts", EUR J NEUR, 8(4), 2001, pp. 299-314
18. Dodel, RC; Berger, K; Oertel, WH
    Health-related quality of life and healthcare utilisation in patients withParkinson's disease - Impact of motor fluctuations and dyskinesias
    PHARMACOECONOMICS
    
    R.C. Dodel et al., "Health-related quality of life and healthcare utilisation in patients withParkinson's disease - Impact of motor fluctuations and dyskinesias", PHARMACOECO, 19(10), 2001, pp. 1013-1038
19. Rembischevski, P; Gemal, AL
    Determination of the influence of borate ion on the degradation of L-alpha-methyldopa using RP-HPLC with photodiode array detection
    JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES
    
    P. Rembischevski e A.L. Gemal, "Determination of the influence of borate ion on the degradation of L-alpha-methyldopa using RP-HPLC with photodiode array detection", J LIQ CHR R, 24(17), 2001, pp. 2661-2671
20. Harth, R; Gerlach, M; Riederer, P; Gotz, ME
    A highly sensitive method for the determination of protein bound 3,4-dihydroxyphenylalanine as a marker for post-translational protein hydroxylation in human tissues ex vivo
    FREE RADICAL RESEARCH
    
    R. Harth et al., "A highly sensitive method for the determination of protein bound 3,4-dihydroxyphenylalanine as a marker for post-translational protein hydroxylation in human tissues ex vivo", FREE RAD RE, 35(2), 2001, pp. 167-174
21. Regier, JC; Mitter, C; Friedlander, TP; Peigler, RS
    Re: Phylogenetic relationships in Sphingidae (Insecta : Lepidoptera): Initial evidence from two nuclear genes
    MOLECULAR PHYLOGENETICS AND EVOLUTION
    
    J.C. Regier et al., "Re: Phylogenetic relationships in Sphingidae (Insecta : Lepidoptera): Initial evidence from two nuclear genes", MOL PHYL EV, 20(2), 2001, pp. 311-316
22. Ascher, JS; Danforth, BN; Ji, SQ
    Phylogenetic utility of the major opsin in bees (Hymenoptera : apoidea): Areassessment
    MOLECULAR PHYLOGENETICS AND EVOLUTION
    
    J.S. Ascher et al., "Phylogenetic utility of the major opsin in bees (Hymenoptera : apoidea): Areassessment", MOL PHYL EV, 19(1), 2001, pp. 76-93
23. Goto, SG; Kimura, MT
    Phylogenetic utility of mitochondrial COI and nuclear Gpdh genes in Drosophila
    MOLECULAR PHYLOGENETICS AND EVOLUTION
    
    S.G. Goto e M.T. Kimura, "Phylogenetic utility of mitochondrial COI and nuclear Gpdh genes in Drosophila", MOL PHYL EV, 18(3), 2001, pp. 404-422
24. Cools, R; Barker, RA; Sahakian, BJ; Robbins, TW
    Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands
    CEREBRAL CORTEX
    
    R. Cools et al., "Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands", CEREB CORT, 11(12), 2001, pp. 1136-1143
25. Furlanut, M; Furlanut, M; Benetello, P
    Monitoring of L-dopa concentrations in Parkinson's disease
    PHARMACOLOGICAL RESEARCH
    
    M. Furlanut et al., "Monitoring of L-dopa concentrations in Parkinson's disease", PHARMAC RES, 43(5), 2001, pp. 423-427
26. Tamilarasu, N; Zhang, J; Hwang, S; Rana, TM
    A new strategy for site-specific protein modification: Analysis of a Tat peptide - TAR RNA interaction
    BIOCONJUGATE CHEMISTRY
    
    N. Tamilarasu et al., "A new strategy for site-specific protein modification: Analysis of a Tat peptide - TAR RNA interaction", BIOCONJ CHE, 12(2), 2001, pp. 135-138
27. Zhang, FP; Bi, SP; Li, HZ; Chen, YJ; Dai, LM
    Application of L-dopa as an electroactive ligand for indirect determination of aluminum in biological samples by differential pulse voltammetry
    ELECTROANALYSIS
    
    F.P. Zhang et al., "Application of L-dopa as an electroactive ligand for indirect determination of aluminum in biological samples by differential pulse voltammetry", ELECTROANAL, 13(12), 2001, pp. 1054-1058
28. Brown, DA
    Skin pigmentation enhancers
    JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
    
    D.A. Brown, "Skin pigmentation enhancers", J PHOTOCH B, 63(1-3), 2001, pp. 148-161
29. Thobois, S; Guillouet, S; Broussolle, E
    Contributions of PET and SPECT to the understanding of the pathophysiologyof Parkinson's disease
    NEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY
    
    S. Thobois et al., "Contributions of PET and SPECT to the understanding of the pathophysiologyof Parkinson's disease", NEUROP CLIN, 31(5), 2001, pp. 321-340
30. Bezard, E; Ravenscroft, P; Gross, CE; Crossman, AR; Brotchie, JM
    Upregulation of striatal preproenkephalin gene expression occurs before the appearance of parkinsonian signs in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys
    NEUROBIOLOGY OF DISEASE
    
    E. Bezard et al., "Upregulation of striatal preproenkephalin gene expression occurs before the appearance of parkinsonian signs in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys", NEUROBIOL D, 8(2), 2001, pp. 343-350
31. Gillings, NM; Bender, D; Falborg, L; Marthi, K; Munk, OL; Cumming, P
    Kinetics of the metabolism of four PET radioligands in living minipigs
    NUCLEAR MEDICINE AND BIOLOGY
    
    N.M. Gillings et al., "Kinetics of the metabolism of four PET radioligands in living minipigs", NUCL MED BI, 28(1), 2001, pp. 97-104
32. Schwarz, EJ; Reger, RL; Alexander, GM; Class, R; Azizi, SA; Prockop, DJ
    Rat marrow stromal cells rapidly transduced with a self-inactivating retrovirus synthesize L-DOPA in vitro
    GENE THERAPY
    
    E.J. Schwarz et al., "Rat marrow stromal cells rapidly transduced with a self-inactivating retrovirus synthesize L-DOPA in vitro", GENE THER, 8(16), 2001, pp. 1214-1223
33. Weller, J; Sun, GC; Zhou, BH; Lan, Q; Hiruma, K; Riddiford, LM
    Isolation and developmental expression of two nuclear receptors, MHR4 and beta FTZ-F1, in the tobacco hornworm, Manduca sexta
    INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY
    
    J. Weller et al., "Isolation and developmental expression of two nuclear receptors, MHR4 and beta FTZ-F1, in the tobacco hornworm, Manduca sexta", INSEC BIO M, 31(8), 2001, pp. 827-837
34. Zhao, XL; Smartt, CT; Li, JY; Christensen, BM
    Aedes aegypti peroxidase gene characterization and developmental expression
    INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY
    
    X.L. Zhao et al., "Aedes aegypti peroxidase gene characterization and developmental expression", INSEC BIO M, 31(4-5), 2001, pp. 481-490
35. Johnson, JK; Li, J; Christensen, BM
    Cloning and characterization of a dopachrome conversion enzyme from the yellow fever mosquito, Aedes aegypti
    INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY
    
    J.K. Johnson et al., "Cloning and characterization of a dopachrome conversion enzyme from the yellow fever mosquito, Aedes aegypti", INSEC BIO M, 31(11), 2001, pp. 1125-1135
36. Bertoldi, M; Voltattorni, CB
    Dopa decarboxylase exhibits low pH half-transaminase and high pH oxidativedeaminase activities toward serotonin (5-hydroxytryptamine)
    PROTEIN SCIENCE
    
    M. Bertoldi e C.B. Voltattorni, "Dopa decarboxylase exhibits low pH half-transaminase and high pH oxidativedeaminase activities toward serotonin (5-hydroxytryptamine)", PROTEIN SCI, 10(6), 2001, pp. 1178-1186
37. Burzio, LA; Waite, JH
    Reactivity of peptidyl-tyrosine to hydroxylation and cross-linking
    PROTEIN SCIENCE
    
    L.A. Burzio e J.H. Waite, "Reactivity of peptidyl-tyrosine to hydroxylation and cross-linking", PROTEIN SCI, 10(4), 2001, pp. 735-740
38. Yamato, H; Kannari, K; Shen, H; Suda, T; Matsunaga, M
    Fluoxetine reduces L-DOPA-derived extracellular DA in the 6-OHDA-lesioned rat striatum?
    NEUROREPORT
    
    H. Yamato et al., "Fluoxetine reduces L-DOPA-derived extracellular DA in the 6-OHDA-lesioned rat striatum?", NEUROREPORT, 12(6), 2001, pp. 1123-1126
39. Ferger, B; Rose, S; Jenner, A; Halliwell, B; Jenner, P
    6-hydroxydopamine increases hydroxyl free radical production and DNA damage in rat striatum
    NEUROREPORT
    
    B. Ferger et al., "6-hydroxydopamine increases hydroxyl free radical production and DNA damage in rat striatum", NEUROREPORT, 12(6), 2001, pp. 1155-1159
40. Love, S
    Damage to nuclear DNA in Lewy body disease
    NEUROREPORT
    
    S. Love, "Damage to nuclear DNA in Lewy body disease", NEUROREPORT, 12(12), 2001, pp. 2725-2729
41. Iravani, MM; Costa, S; Jackson, MJ; Tel, BC; Cannizzaro, C; Pearce, RKB; Jenner, P
    GDNF reverses priming for dyskinesia in MPTP-treated, L-DOPA-primed commonmarmosets
    EUROPEAN JOURNAL OF NEUROSCIENCE
    
    M.M. Iravani et al., "GDNF reverses priming for dyskinesia in MPTP-treated, L-DOPA-primed commonmarmosets", EUR J NEURO, 13(3), 2001, pp. 597-608
42. Grant, S; Patel, NN; Philp, AR; Grey, CNB; Lucas, RD; Foster, RG; Bowmaker, JK; Jeffery, G
    Rod photopigment deficits in albinos are specific to mammals and arise during retinal development
    VISUAL NEUROSCIENCE
    
    S. Grant et al., "Rod photopigment deficits in albinos are specific to mammals and arise during retinal development", VIS NEUROSC, 18(2), 2001, pp. 245-251
43. Shen, B; Samaraweera, P; Rosenberg, B; Orlow, SJ
    Ocular albinism type 1: More than meets the eye
    PIGMENT CELL RESEARCH
    
    B. Shen et al., "Ocular albinism type 1: More than meets the eye", PIGM CELL R, 14(4), 2001, pp. 243-248
44. Purrello, M; Scalia, M; Corsaro, C; Di Pietro, C; Piro, S; Sichel, G
    Melanosynthesis, differentiation, and apoptosis in Kupffer cells from Ranaesculenta
    PIGMENT CELL RESEARCH
    
    M. Purrello et al., "Melanosynthesis, differentiation, and apoptosis in Kupffer cells from Ranaesculenta", PIGM CELL R, 14(2), 2001, pp. 126-131
45. Pattison, DI; Davies, MJ; Levina, A; Dixon, NE; Lay, PA
    Chromium(VI) reduction by catechol(amine)s results in DNA cleavage in vitro: Relevance to chromium genotoxicity
    CHEMICAL RESEARCH IN TOXICOLOGY
    
    D.I. Pattison et al., "Chromium(VI) reduction by catechol(amine)s results in DNA cleavage in vitro: Relevance to chromium genotoxicity", CHEM RES T, 14(5), 2001, pp. 500-510
46. Kato, Y; Kitamoto, N; Kawai, Y; Osawa, T
    The hydrogen peroxide/copper ion system, but not other metal-catalyzed oxidation systems, produces protein-bound dityrosine
    FREE RADICAL BIOLOGY AND MEDICINE
    
    Y. Kato et al., "The hydrogen peroxide/copper ion system, but not other metal-catalyzed oxidation systems, produces protein-bound dityrosine", FREE RAD B, 31(5), 2001, pp. 624-632
47. Jung, YJ; Surh, YJ
    Oxidative DNA damage and cytotoxicity induced by copper-stimulated redox cycling of salsolinol, a neurotoxic tetrahydroisoquinoline alkaloid
    FREE RADICAL BIOLOGY AND MEDICINE
    
    Y.J. Jung e Y.J. Surh, "Oxidative DNA damage and cytotoxicity induced by copper-stimulated redox cycling of salsolinol, a neurotoxic tetrahydroisoquinoline alkaloid", FREE RAD B, 30(12), 2001, pp. 1407-1417
48. Marin, C; Jimenez, A; Bonastre, M; Vila, M; Agid, Y; Hirsch, EC; Tolosa, E
    LY293558, an AMPA glutamate receptor antagonist, prevents and reverses levodopa-induced motor alterations in parkinsonian rats
    SYNAPSE
    
    C. Marin et al., "LY293558, an AMPA glutamate receptor antagonist, prevents and reverses levodopa-induced motor alterations in parkinsonian rats", SYNAPSE, 42(1), 2001, pp. 40-47
49. Cumming, P; Munk, OL; Doudet, D
    Loss of metabolites from monkey striatum during PET with FDOPA
    SYNAPSE
    
    P. Cumming et al., "Loss of metabolites from monkey striatum during PET with FDOPA", SYNAPSE, 41(3), 2001, pp. 212-218
50. Danielsen, EH; Smith, D; Hermansen, F; Gjedde, A; Cumming, P
    Acute neuroleptic stimulates DOPA decarboxylase in porcine brain in vivo
    SYNAPSE
    
    E.H. Danielsen et al., "Acute neuroleptic stimulates DOPA decarboxylase in porcine brain in vivo", SYNAPSE, 41(2), 2001, pp. 172-175
51. Ruottinen, HM; Niinivirta, M; Bergman, J; Oikonen, V; Solin, O; Eskola, O; Eronen, E; Sonninen, P; Rinne, UK
    Detection of response to COMT inhibition in FDOPA PET in advanced Parkinson's disease requires prolonged imaging
    SYNAPSE
    
    H.M. Ruottinen et al., "Detection of response to COMT inhibition in FDOPA PET in advanced Parkinson's disease requires prolonged imaging", SYNAPSE, 40(1), 2001, pp. 19-26
52. Pinna, A; Fenu, S; Morelli, M
    Motor stimulant effects of the adenosine A(2A) receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats
    SYNAPSE
    
    A. Pinna et al., "Motor stimulant effects of the adenosine A(2A) receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats", SYNAPSE, 39(3), 2001, pp. 233-238
53. Spivak, B; Vered, Y; Yoran-Hegesh, R; Graff, E; Averbuch, E; Vinokurow, S; Weizman, A; Mester, R
    The influence of three months of methylphenidate treatment on platelet-poor plasma biogenic amine levels in boys with attention deficit hyperactivitydisorder
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    
    B. Spivak et al., "The influence of three months of methylphenidate treatment on platelet-poor plasma biogenic amine levels in boys with attention deficit hyperactivitydisorder", HUM PSYCHOP, 16(4), 2001, pp. 333-337
54. Saletu, M; Anderer, P; Saletu, B; Hauer, C; Mandl, M; Semler, B; Saletu-Zyhlarz, G
    Sleep laboratory studies in periodic limb movement disorder (PLMD) patients as compared with normals and acute effects of ropinirole
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    
    M. Saletu et al., "Sleep laboratory studies in periodic limb movement disorder (PLMD) patients as compared with normals and acute effects of ropinirole", HUM PSYCHOP, 16(2), 2001, pp. 177-187
55. Walters, AS; Winkelmann, J; Trenkwalder, C; Fry, JM; Kataria, V; Wagner, M; Sharma, R; Hening, W; Li, L
    Long-term follow-up on restless legs syndrome patients treated with opioids
    MOVEMENT DISORDERS
    
    A.S. Walters et al., "Long-term follow-up on restless legs syndrome patients treated with opioids", MOVEMENT D, 16(6), 2001, pp. 1105-1109
56. Yee, RE; Irwin, I; Milonas, C; Stout, DB; Huang, SC; Shoghi-Jadid, K; Satyamurthy, N; Delanney, LE; Togaski, DM; Farahani, KF; Delfani, K; Janson, AM; Phelps, ME; Langston, JW; Barrio, JR
    Novel observations with FDOPA-PET imaging after early nigrostriatal damage
    MOVEMENT DISORDERS
    
    R.E. Yee et al., "Novel observations with FDOPA-PET imaging after early nigrostriatal damage", MOVEMENT D, 16(5), 2001, pp. 838-848
57. Nurmi, E; Ruottinen, HM; Bergman, J; Haaparanta, M; Solin, O; Sonninen, P; Rinne, JO
    Rate of progression in Parkinson's disease: A 6-[F-18]fluoro-L-dopa PET study
    MOVEMENT DISORDERS
    
    E. Nurmi et al., "Rate of progression in Parkinson's disease: A 6-[F-18]fluoro-L-dopa PET study", MOVEMENT D, 16(4), 2001, pp. 608-615
58. Maratos, EC; Jackson, MJ; Pearce, RKB; Jenner, P
    Antiparkinsonian activity and dyskinesia risk of ropinirole and L-DOPA combination therapy in drug naive MPTP-lesioned common marmosets (Callithrix jacchus)
    MOVEMENT DISORDERS
    
    E.C. Maratos et al., "Antiparkinsonian activity and dyskinesia risk of ropinirole and L-DOPA combination therapy in drug naive MPTP-lesioned common marmosets (Callithrix jacchus)", MOVEMENT D, 16(4), 2001, pp. 631-641
59. Fox, SH; Henry, B; Hill, MP; Peggs, D; Crossman, AR; Brotchie, JM
    Neural mechanisms underlying peak-dose dyskinesia induced by levodopa and apomorphine are distinct: Evidence from the effects of the alpha(2) adrenoceptor antagonist idazoxan
    MOVEMENT DISORDERS
    
    S.H. Fox et al., "Neural mechanisms underlying peak-dose dyskinesia induced by levodopa and apomorphine are distinct: Evidence from the effects of the alpha(2) adrenoceptor antagonist idazoxan", MOVEMENT D, 16(4), 2001, pp. 642-650
60. Rascol, O; Arnulf, I; Paul, HPS; Brefel-Courbon, C; Vidailhet, M; Thalamas, C; Bonnet, AM; Descombes, S; Bejjani, B; Fabre, N; Montastruc, JL; Agid, Y
    Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease
    MOVEMENT DISORDERS
    
    O. Rascol et al., "Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease", MOVEMENT D, 16(4), 2001, pp. 708-713
61. Datla, KP; Blunt, SB; Dexter, DT
    Chronic L-DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, inrats with partial 6-OHDA or FeCl3 nigrostriatal lesions
    MOVEMENT DISORDERS
    
    K.P. Datla et al., "Chronic L-DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, inrats with partial 6-OHDA or FeCl3 nigrostriatal lesions", MOVEMENT D, 16(3), 2001, pp. 424-434
62. Petzinger, GM; Quik, M; Ivashina, E; Jakowec, MW; Jakubiak, M; Di Monte, D; Langston, JW
    Reliability and validity of a new global dyskinesia rating scale in the MPTP-lesioned non-human primate
    MOVEMENT DISORDERS
    
    G.M. Petzinger et al., "Reliability and validity of a new global dyskinesia rating scale in the MPTP-lesioned non-human primate", MOVEMENT D, 16(2), 2001, pp. 202-207
63. Sedlakova, A; Kohut, A; Sarissky, M
    Changes of gastric lipase activity after ethanol and indomethacin administration: Influence of pretreatment with allopurinol, pentoxifylline and L-DOPA
    PHYSIOLOGICAL RESEARCH
    
    A. Sedlakova et al., "Changes of gastric lipase activity after ethanol and indomethacin administration: Influence of pretreatment with allopurinol, pentoxifylline and L-DOPA", PHYSL RES, 50(3), 2001, pp. 299-307
64. Ghaemi, M; Rudolf, J; Hilker, R; Herholz, K; Heiss, WD
    Increased pineal Fdopa uptake is related to severity of Parkinson's disease - A PET study
    JOURNAL OF PINEAL RESEARCH
    
    M. Ghaemi et al., "Increased pineal Fdopa uptake is related to severity of Parkinson's disease - A PET study", J PINEAL R, 30(4), 2001, pp. 213-219
65. Friedman, J; Standaert, DG
    Dystonia and its disorders
    NEUROLOGIC CLINICS
    
    J. Friedman e D.G. Standaert, "Dystonia and its disorders", NEUROL CLIN, 19(3), 2001, pp. 681
66. Silber, MH
    Sleep disorders
    NEUROLOGIC CLINICS
    
    M.H. Silber, "Sleep disorders", NEUROL CLIN, 19(1), 2001, pp. 173
67. Marcolino-Junior, LH; Teixeira, MFS; Pereira, AV; Fatibello, O
    Flow Injection Determination of levodopa in tablets using a solid-phase reactor containing lead(IV) dioxide immobilized
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    
    L.H. Marcolino-Junior et al., "Flow Injection Determination of levodopa in tablets using a solid-phase reactor containing lead(IV) dioxide immobilized", J PHARM B, 25(3-4), 2001, pp. 393-398
68. Grange, S; Holford, NHG; Guentert, TW
    A pharmacokinetic model to predict the PK interaction of l-dopa and benserazide in rats
    PHARMACEUTICAL RESEARCH
    
    S. Grange et al., "A pharmacokinetic model to predict the PK interaction of l-dopa and benserazide in rats", PHARM RES, 18(8), 2001, pp. 1174-1184
69. El-Ahmady, SH; Nessler, CL
    Cellular localization of tyrosine decarboxylase expression in transgenic opium poppy and tobacco
    PLANT CELL REPORTS
    
    S.H. El-Ahmady e C.L. Nessler, "Cellular localization of tyrosine decarboxylase expression in transgenic opium poppy and tobacco", PL CELL REP, 20(4), 2001, pp. 313-317
70. Zheleva, AM; Gadjeva, VG
    Spin labelled nitrosoureas and triazenes and their non-labelled clinicallyused analogues - a comparative study on their physicochemical properties and antimelanomic effects
    INTERNATIONAL JOURNAL OF PHARMACEUTICS
    
    A.M. Zheleva e V.G. Gadjeva, "Spin labelled nitrosoureas and triazenes and their non-labelled clinicallyused analogues - a comparative study on their physicochemical properties and antimelanomic effects", INT J PHARM, 212(2), 2001, pp. 257-266
71. Huang, SY; Hu, JJ; Wang, TT
    Effects of gas composition on the cell growth and L- DOPA production in the suspension culture of Stizolobium hassjoo
    JOURNAL OF THE CHINESE INSTITUTE OF CHEMICAL ENGINEERS
    
    S.Y. Huang et al., "Effects of gas composition on the cell growth and L- DOPA production in the suspension culture of Stizolobium hassjoo", J CH INST C, 32(1), 2001, pp. 1-11
72. Jankovic, J
    Parkinson's diseasetherapy: treatment of early and late disease
    CHINESE MEDICAL JOURNAL
    
    J. Jankovic, "Parkinson's diseasetherapy: treatment of early and late disease", CHIN MED J, 114(3), 2001, pp. 227-234
73. Togasaki, DM; Tan, L; Protell, P; Di Monte, DA; Quik, M; Langston, JW
    Levodopa induces dyskinesias in normal squirrel monkeys
    ANNALS OF NEUROLOGY
    
    D.M. Togasaki et al., "Levodopa induces dyskinesias in normal squirrel monkeys", ANN NEUROL, 50(2), 2001, pp. 254-257
74. Berendse, HW; Booij, J; Francot, CMJE; Bergmans, PLM; Hijman, R; Stoof, JC; Wolters, EC
    Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell
    ANNALS OF NEUROLOGY
    
    H.W. Berendse et al., "Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell", ANN NEUROL, 50(1), 2001, pp. 34-41
75. Hilker, R; Klein, C; Ghaemi, M; Kis, B; Strotmann, T; Ozelius, LJ; Lenz, O; Vieregge, P; Herholz, K; Heiss, WD; Pramstaller, PP
    Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene
    ANNALS OF NEUROLOGY
    
    R. Hilker et al., "Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene", ANN NEUROL, 49(3), 2001, pp. 367-376
76. Poulikakos, P; Vassilacopoulou, D; Fragoulis, EG
    L-DOPA decarboxylase association with membranes in mouse brain
    NEUROCHEMICAL RESEARCH
    
    P. Poulikakos et al., "L-DOPA decarboxylase association with membranes in mouse brain", NEUROCHEM R, 26(5), 2001, pp. 479-485
77. Rascol, O; Fabre, N
    Dyskinesia: L-dopa-induced and tardive dyskinesia
    CLINICAL NEUROPHARMACOLOGY
    
    O. Rascol e N. Fabre, "Dyskinesia: L-dopa-induced and tardive dyskinesia", CLIN NEUROP, 24(6), 2001, pp. 313-323
78. Camicioli, R; Lea, E; Nutt, JG; Sexton, G; Oken, BS
    Methylphenidate increases the motor effects of L-dopa in Parkinson's disease: A pilot study
    CLINICAL NEUROPHARMACOLOGY
    
    R. Camicioli et al., "Methylphenidate increases the motor effects of L-dopa in Parkinson's disease: A pilot study", CLIN NEUROP, 24(4), 2001, pp. 208-213
79. Heikkinen, H; Nutt, JG; LeWitt, PA; Koller, WC; Gordin, A
    The effects of different repeated doses of entacapone on the pharmacokinetics of L-Dopa and on the clinical response to L-Dopa in Parkinson's disease
    CLINICAL NEUROPHARMACOLOGY
    
    H. Heikkinen et al., "The effects of different repeated doses of entacapone on the pharmacokinetics of L-Dopa and on the clinical response to L-Dopa in Parkinson's disease", CLIN NEUROP, 24(3), 2001, pp. 150-157
80. Micallef-Roll, J; Rihet, P; Hasbroucq, T; Possamai, C; Blin, O
    Levodopa-induced drowsiness in healthy volunteers: Results of a choice reaction time test combined with a subjective evaluation of sedation
    CLINICAL NEUROPHARMACOLOGY
    
    J. Micallef-Roll et al., "Levodopa-induced drowsiness in healthy volunteers: Results of a choice reaction time test combined with a subjective evaluation of sedation", CLIN NEUROP, 24(2), 2001, pp. 91-94
81. Djaldetti, R; Rosmarin, V; Ziv, I; Melamed, E
    The pharmacokinetic profile of the "first ever" oral dose of levodopa in de novo patients with Parkinson's disease
    CLINICAL NEUROPHARMACOLOGY
    
    R. Djaldetti et al., "The pharmacokinetic profile of the "first ever" oral dose of levodopa in de novo patients with Parkinson's disease", CLIN NEUROP, 24(2), 2001, pp. 95-98
82. Offen, D; Panet, H; Galili-Mosberg, R; Melamed, E
    Catechol-O-methyltransferase decreases levodopa toxicity in vitro
    CLINICAL NEUROPHARMACOLOGY
    
    D. Offen et al., "Catechol-O-methyltransferase decreases levodopa toxicity in vitro", CLIN NEUROP, 24(1), 2001, pp. 27-30
83. Augustyniak, W; Kanski, R; Kanska, M
    Synthesis of carbon-14 labeled [1-C-14]-, and [2-C-14]-L-tyrosine
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    
    W. Augustyniak et al., "Synthesis of carbon-14 labeled [1-C-14]-, and [2-C-14]-L-tyrosine", J LABEL C R, 44(8), 2001, pp. 553-560
84. Chan, PLS; Holford, NHG
    Drug treatment effects on disease progression
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY
    
    P.L.S. Chan e N.H.G. Holford, "Drug treatment effects on disease progression", ANN R PHARM, 41, 2001, pp. 625-659
85. Hoegerle, S; Altehoefer, C; Ghanem, N; Brink, I; Moser, E; Nitzsche, E
    F-18-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    
    S. Hoegerle et al., "F-18-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels", EUR J NUCL, 28(1), 2001, pp. 64-71
86. Dudesek, A; Roschinger, W; Muntau, AC; Seidel, J; Leupold, D; Thony, B; Blau, N
    Molecular analysis and long-term follow-up of patients with different forms of 6-pyruvoyl-tetrahydropterin synthase deficiency
    EUROPEAN JOURNAL OF PEDIATRICS
    
    A. Dudesek et al., "Molecular analysis and long-term follow-up of patients with different forms of 6-pyruvoyl-tetrahydropterin synthase deficiency", EUR J PED, 160(5), 2001, pp. 267-276
87. Djaldetti, R; Melamed, E
    New therapies for Parkinson's disease
    JOURNAL OF NEUROLOGY
    
    R. Djaldetti e E. Melamed, "New therapies for Parkinson's disease", J NEUROL, 248(5), 2001, pp. 357-362
88. Krystkowiak, P; Blatt, JL; Bourriez, JL; Duhamel, A; Perina, M; Kemoun, G; Blond, S; Guieu, JD; Destee, A; Defebvre, L
    Chronic bilateral pallidal stimulation and levodopa do not improve gait inthe same way in Parkinson's disease: a study using video motion analysis system
    JOURNAL OF NEUROLOGY
    
    P. Krystkowiak et al., "Chronic bilateral pallidal stimulation and levodopa do not improve gait inthe same way in Parkinson's disease: a study using video motion analysis system", J NEUROL, 248(11), 2001, pp. 944-949
89. Cakir, S; Bicer, E; Eleman, A
    Synthesis, spectroscopic and voltammetric studies of mixed-ligand copper(II) complexes of amino acids
    TRANSITION METAL CHEMISTRY
    
    S. Cakir et al., "Synthesis, spectroscopic and voltammetric studies of mixed-ligand copper(II) complexes of amino acids", TRANSIT MET, 26(1-2), 2001, pp. 89-95
90. Siddhuraju, P; Becker, K
    Rapid reversed-phase high performance liquid chromatographic method for the quantification of L-Dopa (L-3,4-dihydroxyphenylalanine), non-methylated and methylated tetrahydroisoquinoline compounds from Mucuna beans
    FOOD CHEMISTRY
    
    P. Siddhuraju e K. Becker, "Rapid reversed-phase high performance liquid chromatographic method for the quantification of L-Dopa (L-3,4-dihydroxyphenylalanine), non-methylated and methylated tetrahydroisoquinoline compounds from Mucuna beans", FOOD CHEM, 72(3), 2001, pp. 389-394
91. Sugaya, Y; Sasaki, Y; Goshima, Y; Kitahama, K; Kusakabe, T; Miyamae, T; Kato, T; Misu, Y
    Autoradiographic studies using L-[C-14]DOPA and L-[H-3]DOPA reveal regional NA(+)-dependent uptake of the neurotransmitter candidate L-DOPA in the CNS
    NEUROSCIENCE
    
    Y. Sugaya et al., "Autoradiographic studies using L-[C-14]DOPA and L-[H-3]DOPA reveal regional NA(+)-dependent uptake of the neurotransmitter candidate L-DOPA in the CNS", NEUROSCIENC, 104(1), 2001, pp. 1-14
92. Lopez, A; Munoz, A; Guerra, MJ; Labandeira-Garcia, JL
    Mechanisms of the effects of exogenous levodopa on the dopamine-denervatedstriatum
    NEUROSCIENCE
    
    A. Lopez et al., "Mechanisms of the effects of exogenous levodopa on the dopamine-denervatedstriatum", NEUROSCIENC, 103(3), 2001, pp. 639-651
93. Hadi, N; Singh, S; Ahmad, A; Zaidi, R
    Strand scission in DNA induced by 5-hydroxytryptamine (Serotonin) in the presence of copper ions
    NEUROSCIENCE LETTERS
    
    N. Hadi et al., "Strand scission in DNA induced by 5-hydroxytryptamine (Serotonin) in the presence of copper ions", NEUROSCI L, 308(2), 2001, pp. 83-86
94. Muller, T; Woitalla, D; Hauptmann, B; Fowler, B; Kuhn, W
    Decrease of methionine and S-adenosylmethionine and increase of homocysteine in treated patients with Parkinson's disease
    NEUROSCIENCE LETTERS
    
    T. Muller et al., "Decrease of methionine and S-adenosylmethionine and increase of homocysteine in treated patients with Parkinson's disease", NEUROSCI L, 308(1), 2001, pp. 54-56
95. Itokazu, N; Yamamoto, K; Ouchi, Y; Cyong, JC
    Establishment of L-3,4-dihydroxyphenilalaninde-induced pharmacological dementia model mouse
    NEUROSCIENCE LETTERS
    
    N. Itokazu et al., "Establishment of L-3,4-dihydroxyphenilalaninde-induced pharmacological dementia model mouse", NEUROSCI L, 305(2), 2001, pp. 123-126
96. Sastre-Coll, A; Esteban, S; Miralles, A; Zanetti, R; Garcia-Sevilla, JA
    The imidazoline receptor ligand 2-(2-benzofuranyl)-2-imidazoline is a dopamine-releasing agent in the rat striatum in vivo
    NEUROSCIENCE LETTERS
    
    A. Sastre-Coll et al., "The imidazoline receptor ligand 2-(2-benzofuranyl)-2-imidazoline is a dopamine-releasing agent in the rat striatum in vivo", NEUROSCI L, 301(1), 2001, pp. 29-32
97. Arai, N; Furukawa, N; Miyamae, T; Goshima, Y; Sasaki, Y; Ohshima, E; Suzuki, F; Fujita, K; Misu, Y
    DOPA cyclohexyl ester, a competitive DOPA antagonist, protects glutamate release and resultant delayed neuron death by transient ischemia in hippocampus CA1 of conscious rats
    NEUROSCIENCE LETTERS
    
    N. Arai et al., "DOPA cyclohexyl ester, a competitive DOPA antagonist, protects glutamate release and resultant delayed neuron death by transient ischemia in hippocampus CA1 of conscious rats", NEUROSCI L, 299(3), 2001, pp. 213-216
98. Zucker, M; Weizman, A; Harel, D; Rehavi, M
    Changes in vesicular monoamine transporter (VMAT2) and synaptophysin in rat substantia nigra and prefrontal cortex induced by psychotropic drugs
    NEUROPSYCHOBIOLOGY
    
    M. Zucker et al., "Changes in vesicular monoamine transporter (VMAT2) and synaptophysin in rat substantia nigra and prefrontal cortex induced by psychotropic drugs", NEUROPSYCHB, 44(4), 2001, pp. 187-191
99. Zeng, BY; Pearce, RKB; MacKenzie, GM; Jenner, P
    Chronic high dose L-dopa treatment does not alter the levels of dopamine D-1, D-2 or D-3 receptor in the striatum of normal monkeys: an autoradiographic study
    JOURNAL OF NEURAL TRANSMISSION
    
    B.Y. Zeng et al., "Chronic high dose L-dopa treatment does not alter the levels of dopamine D-1, D-2 or D-3 receptor in the striatum of normal monkeys: an autoradiographic study", J NEURAL TR, 108(8-9), 2001, pp. 925-941
100. Winogrodzka, A; Bergmans, P; Booij, J; van Royen, EA; Janssen, AGM; Wolters, EC
     [I-123]FP-CIT SPECT is a useful method to monitor the rate of dopaminergicdegeneration in early-stage Parkinson's disease
     JOURNAL OF NEURAL TRANSMISSION
     
     A. Winogrodzka et al., "[I-123]FP-CIT SPECT is a useful method to monitor the rate of dopaminergicdegeneration in early-stage Parkinson's disease", J NEURAL TR, 108(8-9), 2001, pp. 1011-1019